Collegium Pharmaceutical COLL
NASDAQ COLL
$27.64 -1.10 (-3.84%)
At close: Aug 20, 2026 · 12:57 PM UTC

Collegium Pharmaceutical (COLL) Return on Invested Capital Growth (3y) (2023 - 2026)

Collegium Pharmaceutical (COLL) Return on Invested Capital Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC Growth (3y) (Qtr)
1 Haleon 43.96 Bn 43.00 Bn - -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn 0.00
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn 0.00
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn -
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn 0.00
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn -
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn 5.00
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Collegium Pharmaceutical 897.05 Mn 747.74 Mn 110.29 Mn 0.00

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2026 1.00
Dec 31, 2025 1.00
Sep 30, 2025 1.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 1.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00